Fatigue in Neurologic Disorders

Published:April 08, 2013DOI:https://doi.org/10.1016/j.jsmc.2013.02.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Victor M. Ropper A.H. Adams and Victor’s principles of neurology. 7th edition. McGraw-Hill, New York2001
        • Pawlikowska T.
        • Chalder T.
        • Hirsch S.R.
        • et al.
        Population based study of fatigue and psychological distress.
        BMJ. 1994; 308: 763-766
        • Krupp L.B.
        Fatigue.
        Butterworth-Heinemann, Philadelphia2003
        • Chaudhuri A.
        • Behan P.O.
        Fatigue and basal ganglia.
        J Neurol Sci. 2000; 179: 34-42
        • Zwarts M.J.
        • Bleijenberg G.
        • van Engelen B.G.
        Clinical neurophysiology of fatigue.
        Clin Neurophysiol. 2008; 119: 2-10
        • Kent-Braun J.
        Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort.
        Eur J Appl Physiol. 1999; 80: 57-63
        • Holmes G.
        • Kaplan J.
        • Gantz N.
        • et al.
        Chronic fatigue syndrome: a working case definition.
        Ann Intern Med. 1988; 108: 387-389
        • Grandjean E.
        Fatigue in industry.
        Br J Ind Med. 1979; 36: 175-186
        • Chaudhuri A.
        • Behan P.O.
        Fatigue in neurological disorders.
        Lancet. 2004; 363: 978-988
        • Gandevia S.C.
        • Allen G.M.
        • Butler J.E.
        • et al.
        Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex.
        J Physiol. 1996; 490: 529-536
        • Taylor J.L.
        • Gandevia S.C.
        Transcranial magnetic stimulation and human muscle fatigue.
        Muscle Nerve. 2001; 24: 18-29
        • Liepert J.
        • Kotterba S.
        • Tegenthoff M.
        • et al.
        Central fatigue assessed by transcranial magnetic stimulation.
        Muscle Nerve. 1996; 19: 1429-1434
        • Brasil-Neto J.P.
        • Cohen L.G.
        • Hallett M.
        Central fatigue as revealed by postexercise decrement of motor evoked potentials.
        Muscle Nerve. 1994; 17: 713-719
        • Samii A.
        • Wassermann E.M.
        • Ikoma K.
        • et al.
        Characterization of postexercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation.
        Neurology. 1996; 46: 1376-1382
        • McKay W.B.
        • Tuel S.M.
        • Sherwood A.M.
        • et al.
        Focal depression of cortical excitability induced by fatiguing muscle contraction: a transcranial magnetic stimulation study.
        Exp Brain Res. 1995; 105: 276-282
        • Brasil-Neto J.P.
        • Pascual-Leone A.
        • Valls-Sole J.
        • et al.
        Postexercise depression of motor evoked potentials: a measure of central nervous system fatigue.
        Exp Brain Res. 1993; 93: 181-184
        • Bigland-Ritchie B.
        • Jones D.A.
        • Hosking G.P.
        Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle.
        Clin Sci Mol Med. 1978; 54: 609-614
        • Beurskens A.J.
        • Bultmann U.
        • Kant I.
        • et al.
        Fatigue among working people: validity of a questionnaire measure.
        Occup Environ Med. 2000; 57: 353-357
        • Albers M.
        • Smets E.M.
        • Vercoulen J.H.
        • et al.
        Abbreviated fatigue questionnaire; a practical tool in the classification of fatigue.
        Ned Tijdschr Geneeskd. 1997; 141 ([in Dutch]): 1526-1530
        • Albers M.
        • Vercoulen J.H.
        • Bleijenberg G.
        Assessment of fatigue. The practical utility of the subjective feeling of fatigue in research and clinical practice.
        in: Vingerhoets A. Assessment in behavioral medicine. Routledge, Brunner (New Zealand)2001: 301-327
        • Krupp L.
        • LaRocca N.
        • Muir-Nash J.
        • et al.
        The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus.
        Arch Neurol. 1989; 46: 1121-1123
        • DeLuca J.
        • Genova H.
        • Capili E.
        • et al.
        Functional neuroimaging of fatigue.
        Phys Med Rehabil Clin N Am. 2009; 20: 325-337
        • Pellicano C.
        • Gallo A.
        • Li X.
        Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.
        Arch Neurol. 2010; 67: 447-453
        • Calabrese M.
        • Rinaldi F.
        • Grossi P.
        • et al.
        Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
        Mult Scler. 2010; 16: 1220-1228
        • Bakshi R.
        • Miletich R.S.
        • Kinkel P.R.
        • et al.
        High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis.
        J Neuroimaging. 1998; 8: 228-234
        • Roelcke U.
        • Kappos L.
        • Lechner-Scott J.
        • et al.
        Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
        Neurology. 1997; 48: 1566-1571
        • White A.T.
        • Lee J.N.
        • Light A.R.
        • et al.
        Brain activation in multiple sclerosis: a BOLD fMRI study of the effects of fatiguing hand exercise.
        Mult Scler. 2009; 15: 580-586
        • Lange G.
        • Wang S.
        • DeLuca J.
        • et al.
        Neuroimaging in chronic fatigue syndrome.
        Am J Med. 1998; 105: 50S-53S
        • Natelson B.H.
        • Cohen J.M.
        • Brassloff I.
        • et al.
        A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome.
        J Neurol Sci. 1993; 120: 213-217
        • Cope H.
        • Pernet A.
        • Kendall B.
        • et al.
        Cognitive functioning and magnetic resonance imaging in chronic fatigue syndrome.
        Br J Psychiatry. 1995; 167: 86-94
        • Lange G.
        • DeLuca J.
        • Maldjian J.
        • et al.
        Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.
        J Neurol Sci. 1999; 17: 3-7
        • Greco A.
        • Tannock C.
        • Brostoff J.
        • et al.
        Brain MR in chronic fatigue syndrome.
        AJNR Am J Neuroradiol. 1997; 18: 1265-1269
        • Schwartz R.B.
        • Komaroff A.L.
        • Garada B.M.
        • et al.
        SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.
        AJR Am J Roentgenol. 1994; 162: 943-951
        • Schmaling K.
        • Lewis D.
        • Fiedelak J.
        • et al.
        Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome.
        Psychosom Med. 2003; 65: 129-136
        • Yoshiuchi K.
        • Farkas J.
        • Natelson B.H.
        Patients with chronic fatigue syndrome have reduced absolute cortical blood flow.
        Clin Physiol Funct Imaging. 2006; 26: 83-86
        • Tirelli U.
        • Chierichetti F.
        • Tavio M.
        • et al.
        Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.
        Am J Med. 1998; 105: 54S-58S
        • Costa D.C.
        • Tannocki C.
        • Brostoff J.
        Brainstem perfusion is impaired in chronic fatigue syndrome.
        QJM. 1995; 88: 767-773
        • Trojan D.A.
        • Cashman N.R.
        Post-poliomyelitis syndrome.
        Muscle Nerve. 2005; 31: 6-19
        • Trojan D.A.
        • Cashman N.R.
        • Shapiro S.
        • et al.
        Predictive factors for post-poliomyelitis syndrome.
        Arch Phys Med Rehabil. 1994; 75: 770-777
        • Östlund G.
        • Wahlin Å.
        • Sunnerhagen K.S.
        • et al.
        Post polio syndrome: fatigued patients a specific subgroup?.
        J Rehabil Med. 2011; 43: 39-45
        • On A.Y.
        • Oncu J.
        • Atamaz F.
        • et al.
        Impact of post-polio fatigue on quality of life.
        J Rehabil Med. 2006; 38: 329-332
        • Trojan D.A.
        • Genrdon D.
        • Cashman N.R.
        Anticholinesterase-responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue.
        J Neurol Sci. 1993; 114: 170-177
        • Bruno R.L.
        • Galski T.
        • DeLuca J.
        The neuropsychology of post-polio fatigue.
        Arch Phys Med Rehabil. 1993; 74: 1061-1065
        • Ostlund G.
        • Borg K.
        • Wahlin A.
        Cognitive functioning in post-polio patients with and without general fatigue.
        J Rehabil Med. 2005; 37: 147-151
        • Bruno R.L.
        • Zimmerman J.R.
        Word finding difficulty as a post-polio sequelae.
        Am J Phys Med Rehabil. 2000; 79: 343-348
        • Bruno R.L.
        • Cohen J.M.
        • Frick N.M.
        The neuroanatomy of post-polio fatigue.
        Arch Phys Med Rehabil. 1994; 75: 498-504
        • Bruno R.
        Abnormal movements in sleep as a post-polio sequelae.
        Am J Phys Med Rehabil. 1998; 77: 339-343
        • Araujo M.A.
        • de Silva T.M.
        • Moreira G.A.
        • et al.
        Sleep disorders frequency in post-polio syndrome patients caused by periodic limb movements.
        Arq Neuropsiquiatr. 2010; 68: 35-38
        • Hsu A.A.
        • Staats B.A.
        “Postpolio” sequelae and sleep-related disordered breathing.
        Mayo Clin Proc. 1998; 73: 216-224
        • Berlly M.H.
        • Strauser W.W.
        • Hall K.M.
        Fatigue in postpolio syndrome.
        Arch Phys Med Rehabil. 1991; 72: 115-118
        • Packer T.L.
        • Martins I.
        • Krefting L.
        Activity and post-polio fatigue.
        Orthopedics. 1991; 14: 1223-1226
        • Agre J.
        • Rodriguez A.
        • Franke T.
        • et al.
        Low-intensity, alternate-day exercise improves muscle performance without apparent adverse affect in postpolio patients.
        Am J Phys Med Rehabil. 1996; 75: 50-58
        • Chan K.M.
        • Amirjani N.
        • Sumrain M.
        • et al.
        Randomized controlled trial of strength training in post-polio patients.
        Muscle Nerve. 2003; 27: 332-338
        • Koopman F.S.
        • Beelen A.
        • Gerrits K.H.
        • et al.
        Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial.
        BMC Neurol. 2010; 18: 8
        • Stein D.P.
        • Dambrosia J.M.
        • Dalakas M.C.
        A double-blind, placebo-controlled, trial of amantadine for the treatment, of fatigue in patients with the post-polio syndrome.
        Ann N Y Acad Sci. 1998; 753: 296-302
        • Bruno R.
        • Zimmerman J.
        • Creange S.
        • et al.
        Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue.
        Am J Phys Med Rehabil. 1996; 75: 340-347
        • Chan K.M.
        • Strohschein F.J.
        • Rydz D.
        • et al.
        Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
        Muscle Nerve. 2006; 33: 138-141
        • Vasconcelos O.M.
        • Prokhorenko O.A.
        • Salajegheh M.K.
        • et al.
        Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
        Neurology. 2007; 68: 1680-1686
        • Farbu E.
        • Rekand T.
        • Vik-Mo E.
        • et al.
        Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study.
        Eur J Neurol. 2007; 14: 60-65
        • Trojan D.A.
        • Collet J.P.
        • Shapiro S.
        • et al.
        A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome.
        Neurology. 1999; 53: 1225-1233
      2. Preston D.C. Shapiro B.E. Electromyography and neuromuscular disorders: clinical-electrophysiological correlates. 2nd edition. Elsevier Butterworth-Heinemann, Philadelphia2005
        • Paul R.H.
        • Cohen R.A.
        • Goldstein J.M.
        • et al.
        Fatigue and its impact on patients with myasthenia gravis.
        Muscle Nerve. 2000; 23: 1402-1406
        • Ramirez C.
        • Piemonte M.E.
        • Callegaro D.
        • et al.
        Fatigue in amyotrophic lateral sclerosis: frequency and associated factors.
        Amyotroph Lateral Scler. 2008; 9: 75-80
        • Lou J.S.
        • Reeves A.
        • Benice T.
        • et al.
        Fatigue and depression are associated with poor quality of life in ALS.
        Neurology. 2003; 60: 122-123
        • Kent-Braun J.A.
        • Miller R.G.
        Central fatigue during isometric exercise in amyotrophic lateral sclerosis.
        Muscle Nerve. 2000; 23: 909-914
        • Sanjak M.
        • Brinkmann J.
        • Beldon D.S.
        • et al.
        Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.
        J Neurol Sci. 2001; 191: 55-59
        • Rabkin J.G.
        • Gordon P.H.
        • McElhiney M.
        • et al.
        Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
        Muscle Nerve. 2009; 39: 297-303
        • Merkies I.S.
        • Schmitz P.I.
        • Samijn J.P.
        • et al.
        Fatigue in immune-mediated polyneuropathies.
        Neurology. 1999; 53: 1648-1654
        • Garssen M.P.
        • Schillings M.L.
        • Van Doorn P.A.
        • et al.
        Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome.
        Muscle Nerve. 2007; 36: 93-99
        • Garssen M.P.
        • van Doorn P.A.
        • Visser G.H.
        Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome.
        J Neurol. 2006; 253: 851-856
        • Garssen M.P.
        • van Koningsveld R.
        • Van Doorn P.A.
        Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.
        J Neurol. 2006; 253: 1143-1146
        • Garssen M.P.
        • Busmann J.B.
        • Scmitz P.I.
        • et al.
        Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.
        Neurology. 2004; 63: 2393-2395
        • Ruhland J.L.
        • Shields R.K.
        The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies.
        Phys Ther. 1997; 77: 1026-1039
        • Garssen M.P.
        • Schmitz P.I.
        • Merlies I.S.
        • et al.
        Amantadine for treatment of fatigue in Guillain-Barré syndrome: a randomised, double blind, placebo controlled, crossover trial.
        J Neurol Neurosurg Psychiatry. 2006; 77: 61-65
        • Carter G.
        • Han J.
        • Mayadev A.
        Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1a: a case series.
        Am J Hosp Palliat Care. 2006; 23: 412-416
        • Kalkman J.S.
        • Schillings M.L.
        • van der Werf S.P.
        • et al.
        Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-1.
        J Neurol Neurosurg Psychiatry. 2005; 76: 1406-1409
        • Salva M.Q.
        • Blumen M.
        • Jacquette A.
        • et al.
        Sleep disorders in childhood-onset myotonic dystrophy type 1.
        Neuromuscul Disord. 2006; 16: 564-570
        • Vercoulen J.H.
        • Hommes O.R.
        • Swanink C.
        • et al.
        The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects.
        Arch Neurol. 1996; 53: 642-649
        • Fisk J.D.
        • Pontefract A.
        • Ritvo P.G.
        • et al.
        The impact of fatigue on patients with multiple sclerosis.
        Can J Neurol Sci. 1994; 21: 9-14
        • Bol Y.
        • Duits A.A.
        • Hupperts R.M.
        • et al.
        The impact of fatigue on cognitive functioning in patients with multiple sclerosis.
        Clin Rehabil. 2010; 24: 854-862
        • Janardhana V.
        • Bakshi R.
        Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.
        J Neurol Sci. 2002; 205: 51-58
        • Amato M.P.
        • Ponziani G.
        • Rossi F.
        • et al.
        Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.
        Mult Scler. 2001; 7: 340-344
        • Flachenecker P.
        • Rufer A.
        • Bihler I.
        • et al.
        Fatigue in MS is related to sympathetic vasomotor dysfunction.
        Neurology. 2003; 61: 851-853
        • Gottschalk M.
        • Kümpfel T.
        • Flachenecker P.
        • et al.
        Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
        Arch Neurol. 2005; 62: 277-280
        • Heesen C.
        • Nawrath L.
        • Reich C.
        • et al.
        Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?.
        J Neurol Neurosurg Psychiatry. 2006; 77: 34-39
        • Leocani L.
        • Colombo B.
        • Magnani G.
        • et al.
        Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement–EEG evidence.
        Neuroimage. 2001; 13: 1186-1192
        • Nielly L.
        • Goodin D.
        • Goodkin D.
        • et al.
        Side effect profile of interferon beta-lb in MS: results of an open label trial.
        Neurology. 1996; 46: 552-553
        • Putzki N.
        • Katsarava Z.
        • Vago S.
        • et al.
        Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients.
        Eur Neurol. 2008; 59: 136-142
        • Ziemssen T.
        • Hoffman J.
        • Apfel R.
        • et al.
        Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis.
        Health Qual Life Outcomes. 2008; 6: 67
        • Metz L.M.
        • Patten S.B.
        • Archibald J.C.
        • et al.
        The effect of immunomodulatory treatment on multiple sclerosis fatigue.
        J Neurol Neurosurg Psychiatry. 2004; 75: 1045-1047
        • Lebrun C.
        • Alchaar H.
        • Bourg V.
        • et al.
        Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue.
        Mult Scler. 2006; 12: 321-324
        • Strober L.B.
        • Arnett P.A.
        An examination of four models predicting fatigue in multiple sclerosis.
        Arch Clin Neuropsychol. 2005; 20: 631-646
        • Stanton B.R.
        • Barnes F.
        • Silber E.
        Sleep and fatigue in multiple sclerosis.
        Mult Scler. 2006; 12: 481-486
        • Attarian H.
        • Brown K.
        • Duntley S.
        • et al.
        The relationship of sleep disturbances and fatigue in multiple sclerosis.
        Arch Neurol. 2004; 61: 525-528
        • Veauthier C.
        • Radbruch H.
        • Gaede G.
        Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
        Mult Scler. 2011; 17: 613-622
        • Bohr K.C.
        • Haas J.
        Sleep related breathing disorders do not explain daytime fatigue in multiple sclerosis.
        Mult Scler. 1998; 4: 289a
        • Zifko U.
        • Rupp M.
        • Schwartz S.
        • et al.
        Modafinil in treatment of fatigue in multiple sclerosis: results of an open-label study.
        J Neurol. 2002; 249: 983-987
        • Rammohan K.W.
        • Rosenberg J.H.
        • Lynn D.J.
        • et al.
        Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
        J Neurol Neurosurg Psychiatry. 2002; 72: 179-183
        • Stankoff B.
        • Waubant E.
        • Confavreux G.
        • et al.
        Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
        Neurology. 2005; 64: 1139-1143
        • Cohen R.
        • Fisher M.
        Amantadine treatment of fatigue associated with multiple sclerosis.
        Arch Neurol. 1989; 46: 676-680
        • Weinshenker B.G.
        • Penman M.
        • Bass B.
        • et al.
        A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
        Neurology. 1992; 42: 1468-1471
        • Brañas P.
        • Jordan R.
        • Fry-Smith A.
        • et al.
        Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
        Health Technol Assess. 2000; 4: 1-61
        • Geisler M.
        • Sliwinski M.
        • Coyle P.K.
        • et al.
        The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
        Arch Neurol. 1996; 53: 185-188
        • Romberg A.
        • Virtanen A.
        • Ruutiainen J.
        Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study.
        Neurology. 2004; 63: 2034-2038
        • Bjarnadottir O.H.
        • Konradsdottir A.D.
        • Reynisdottir K.
        • et al.
        Multiple sclerosis and brief moderate exercise: a randomised study.
        Mult Scler. 2007; 13: 776-782
        • Motl R.W.
        • Gosney J.L.
        Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis.
        Mult Scler. 2008; 14: 129-135
        • van Kessel K.
        • Moss-Morris R.
        • Willoughby E.
        • et al.
        A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue.
        Psychosom Med. 2008; 70: 205-213
        • Ghahari S.
        • Leigh Packer T.
        • Passmore A.E.
        Effectiveness of an online fatigue self-management programme for people with chronic neurological conditions: a randomized controlled trial.
        Clin Rehabil. 2010; 24: 727-744
        • de Carvalho M.
        • Motta R.
        • Konrad G.
        • et al.
        A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis.
        Mult Scler. 2012; 18: 82-89
        • Vuletić V.
        • Lezaić Z.
        • Morović S.
        Post-stroke fatigue.
        Acta Clin Croat. 2011; 50: 341-344
        • Christensen D.
        • Johnsen S.P.
        • Watt T.
        • et al.
        Dimensions of post-stroke fatigue: a two-year follow-up study.
        Cerebrovasc Dis. 2008; 26: 134-141
        • Ingles J.
        • Eskes G.
        • Phillips S.
        Fatigue after stroke.
        Arch Phys Med Rehabil. 1999; 80: 173-178
        • Snaphaan L.
        • van der Werf S.
        • de Leeuw F.E.
        Time course and risk factors of post-stroke fatigue: a prospective cohort study.
        Eur J Neurol. 2011; 18: 611-617
        • Andersen G.
        • Christensen D.
        • Kirkevold M.
        • et al.
        Post-stroke fatigue and return to work: a 2-year follow-up.
        Acta Neurol Scand. 2012; 125: 248-253
        • Lynch J.
        • Meade G.
        • Grieg C.
        • et al.
        Fatigue after stroke: the development and evaluation of a case definition.
        J Psychosom Res. 2007; 63: 539-544
        • Choi-Kwon S.
        • Choi J.
        • Kwon S.U.
        • et al.
        Fluoxetine is not effective in the treatment of poststroke fatigue: a double-blind, placebo-controlled study.
        Cerebrovasc Dis. 2007; 23: 103-108
        • McGeough E.
        • Pollock A.
        • Smith L.N.
        • et al.
        Interventions for post-stroke fatigue.
        Cochrane Database Syst Rev. 2009; (CD007030)
        • Freidman J.
        • Friedman H.
        Fatigue in Parkinson's disease.
        Neurology. 1993; 43: 2016-2018
        • Karlsen K.
        • Larsen J.P.
        • Tandberg E.
        • et al.
        Fatigue in patients with Parkinson's disease.
        Mov Disord. 1999; 14: 237-241
        • Herlofson K.
        • Larsen J.P.
        The influence of fatigue on health-related quality of life in patients with Parkinson's disease.
        Acta Neurol Scand. 2003; 107: 1-6
        • Garber C.E.
        • Friedman J.
        Effects of fatigue on physical activity and function in patients with Parkinson’s disease.
        Neurology. 2003; 60: 1119-1124
        • Pavese N.
        • Metta V.
        • Bose S.
        • et al.
        Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction.
        Brain. 2010; 133: 3434-3443
        • Abe K.
        • Takanashi M.
        • Yanagihara T.
        Fatigue in patients with Parkinson's disease.
        Behav Neurol. 2000; 12: 103-106
        • Ziv I.
        • Avraham M.
        • Michealov Y.
        • et al.
        Enhanced fatigue during motor performance in patients with Parkinson's disease.
        Neurology. 1998; 51: 1583-1586
      3. Chokroverty S. Sleep disorders medicine: basic science, technical considerations and clinical aspects. 3rd edition. Saunders-Elsevier, Philadelphia2009
        • Havlikova E.
        • van Dijk J.P.
        • Rosenberger J.
        • et al.
        Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep.
        J Neurol Sci. 2008; 270: 107-113
        • Lou J.S.
        • Kearns G.
        • Benice T.
        • et al.
        Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
        Mov Disord. 2003; 18: 1108-1114
        • Dobkin R.D.
        • Allen L.
        • Menza M.
        Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study.
        Mov Disord. 2007; 22: 946-952
        • Buchwald D.
        • Umali P.
        • Umali J.
        • et al.
        Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system.
        Ann Intern Med. 1995; 123: 81-88
        • Wessely S.
        • Chalder T.
        • Hirsch S.
        • et al.
        The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study.
        Am J Public Health. 1997; 87: 1449-1455
        • Jason L.
        • Richman J.
        • Rademaker A.
        • et al.
        A community-based study of chronic fatigue syndrome.
        Arch Intern Med. 1999; 159: 2129-2137
        • Nater U.M.
        • Lin J.M.
        • Maloney E.M.
        • et al.
        Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population.
        Psychosom Med. 2009; 71: 557-565
        • Wessely S.
        • Powell R.
        Fatigue syndromes: a comparison of chronic “postviral” fatigue with neuromuscular and affective disorders.
        J Neurol Neurosurg Psychiatry. 1989; 52: 940-948
        • Hickie I.
        • Lloyd A.
        • Wakefield D.
        • et al.
        The psychiatric status of patients with the chronic fatigue syndrome.
        Br J Psychiatry. 1990; 156: 534-540
        • Fukuda K.
        • Straus S.
        • Hickie I.
        • et al.
        The chronic fatigue syndrome: a comprehensive approach to its definition and study.
        Ann Intern Med. 1994; 121: 953-959
        • Buchwald D.
        • Ashley R.L.
        • Pearlman T.
        • et al.
        Viral serologies in patients with chronic fatigue and chronic fatigue syndrome.
        J Med Virol. 1996; 50: 25-30
        • Mawle A.
        • Nisenbaum R.
        • Dobbins J.
        • et al.
        Seroepidemiology of chronic fatigue syndrome: a case-control study.
        Clin Infect Dis. 1995; 21: 1386-1389
        • Lombardi V.C.
        • Ruscetti F.W.
        • Das Gupta J.
        • et al.
        Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
        Science. 2009; 326: 585-589
        • Satterfield B.
        • Garcia R.
        • Jia H.
        • et al.
        Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses.
        Retrovirology. 2011; 8: 12
        • Landay A.L.
        • Lennett E.T.
        • Jessop C.
        Chronic fatigue syndrome: clinical condition associated with immune activation.
        Lancet. 1991; 338: 707-712
        • Lorussoa L.
        • Mikhaylovab S.
        • Capellic E.
        • et al.
        Immunological aspects of chronic fatigue syndrome.
        Autoimmun Rev. 2009; 8: 287-291
        • Schillings M.L.
        • Kalkmanb J.S.
        • van der Werf S.P.
        • et al.
        Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome.
        Clin Neurophysiol. 2004; 115: 2518-2524
        • Mariman A.
        • Vogelaers D.
        • Hanoulle I.
        • et al.
        Subjective sleep quality and daytime sleepiness in a large sample of patients with chronic fatigue syndrome (CFS).
        Acta Clin Belg. 2012; 67: 19-24
        • Morriss R.
        • Sharpe M.
        • Sharpley A.L.
        • et al.
        Abnormalities of sleep in patients with the chronic fatigue syndrome.
        BMJ. 1993; 306: 1161
        • Krupp L.
        • Jandorf L.
        • Coyle P.K.
        • et al.
        Sleep disturbance in chronic fatigue syndrome.
        J Psychosom Res. 1993; 37: 325-331
        • Buchwald D.
        • Pascauly R.
        • Bombardier C.
        • et al.
        Sleep disorders in patients with chronic fatigue.
        Clin Infect Dis. 1994; 18: S68-S72
        • Sharpley A.
        • Clements A.
        • Hawton K.
        • et al.
        Do patients with “pure” chronic fatigue syndrome (neurasthenia) have abnormal sleep?.
        Psychosom Med. 1997; 59: 592-596
        • Fischler B.
        • Le Bon O.
        • Hoffmann G.
        • et al.
        Sleep anomalies in the chronic fatigue syndrome.
        Neuropsychobiology. 1997; 35: 115-122
        • Manu P.
        • Lane T.
        • Matthews D.
        • et al.
        Alpha-delta sleep in patients with a chief complaint of chronic fatigue.
        South Med J. 1994; 87: 465-470
        • McKenzie R.
        • O'Fallon A.
        • Dale J.
        • et al.
        Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.
        JAMA. 1998; 280: 1061-1066
        • Moorkens G.
        • Wynants H.
        • Abs R.
        Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study.
        Growth Horm IGF Res. 1998; 8: 131-133
        • Peterson P.
        • Shepard J.
        • Macres M.
        • et al.
        A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome.
        Am J Med. 1990; 89: 554-560
        • Lloyd A.
        • Hickie I.
        • Wakefield D.
        • et al.
        A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome.
        Am J Med. 1990; 89: 561-568
        • Vollmer-Conna U.
        • Hickie I.
        • Hadzi-Pavlovic D.
        • et al.
        Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.
        Am J Med. 1997; 103: 38-43
        • Deale A.
        • Chalder T.
        • Marks I.
        Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.
        Am J Psychiatry. 1997; 154: 408-414
        • Malouff J.
        • Thorsteinsson E.
        • Rooke S.
        Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis.
        Clin Psychol Rev. 2008; 28: 736-745
        • Butler S.
        • Chalder T.
        • Ron M.
        • et al.
        Cognitive behaviour therapy in chronic fatigue syndrome.
        J Neurol Neurosurg Psychiatry. 1991; 54: 153-158
        • Delae A.
        • Chaldera T.
        • Wesselya S.
        Illness beliefs and treatment outcome in chronic fatigue syndrome.
        J Psychosom Res. 1998; 45: 77-83
        • Prins J.
        • Bleijenberg G.
        • Bazelmans E.
        • et al.
        Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.
        Lancet. 2001; 357: 841-847,
        • Deale A.
        • Husain K.
        • Chalder T.
        • et al.
        Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study.
        Am J Psychiatry. 2001; 158: 2038-2042
        • Freidberg F.
        • Krupp L.
        A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression.
        Clin Infect Dis. 1994; 18: S105-S110
        • de Lange F.
        • Koers A.
        • Kalkman J.
        Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome.
        Brain. 2008; 131: 2172-2180
        • Fulchera K.
        • White P.
        Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome.
        BMJ. 1997; 314: 1647-1652
        • Powell P.
        • Bentall R.
        • Nye F.
        Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.
        BMJ. 2001; 322: 387
        • Neill J.
        • Belan I.
        • Ried K.
        Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review.
        J Adv Nurs. 2006; 56: 617-635
        • Cairns R.
        • Hotopf M.
        A systematic review describing the prognosis of chronic fatigue syndrome.
        Occup Med (Lond). 2005; 55: 20-31
        • Wearden A.J.
        • Morriss R.K.
        • Strickland P.L.
        • et al.
        Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
        Br J Psychiatry. 1998; 172: 485-490
        • Vercoulen J.H.
        • Hoofs M.P.
        • Bleijenberg G.
        • et al.
        Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
        Lancet. 1996; 347: 858-861
        • Hill N.
        • Tiersky L.
        • Scavella V.
        • et al.
        Natural history of severe chronic fatigue syndrome.
        Arch Phys Med Rehabil. 1999; 80: 1090-1094
        • Joyce J.
        • Hotopf M.
        • Wessley S.
        The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review.
        QJM. 1997; 90: 223-233
        • Rimes K.
        • Goodman R.
        • Hotopf M.
        • et al.
        Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study.
        Pediatrics. 2007; 119: e603-e609
        • Gill A.
        • Dosen A.
        • Ziegler J.
        Chronic fatigue syndrome in adolescents: a follow-up study.
        Arch Pediatr Adolesc Med. 2004; 158: 225-229
        • Mills P.J.
        • Kim J.
        • Bardwell W.
        • et al.
        Predictors of fatigue in obstructive sleep apnea.
        Sleep Breath. 2008; 12: 397-399
        • Bardwell W.A.
        • Moore P.
        • Anconi-Israel S.
        • et al.
        Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity?.
        Am J Psychiatry. 2003; 160: 350-355
        • Aguillard R.N.
        • Riedel B.W.
        • Lichstein K.L.
        • et al.
        Daytime functioning in obstructive sleep apnea patients: exercise tolerance, subjective fatigue, and sleepiness.
        Appl Psychophysiol Biofeedback. 1998; 23: 207-217
        • Yue H.J.
        • Bardwell W.
        • Ancoli-Israel S.
        • et al.
        Arousal frequency is associated with increased fatigue in obstructive sleep apnea.
        Sleep Breath. 2009; 13: 331-339
        • Tomfohr L.M.
        • Ancoli-Israel S.
        • Loredo J.S.
        • et al.
        Effects of continuous positive airway pressure on fatigue and sleepiness in patients with obstructive sleep apnea: data from a randomized controlled trial.
        Sleep. 2011; 34: 121-126
        • Droogleever Fortuyn H.A.
        • Fronczek R.
        • Smitshoek M.
        • et al.
        Severe fatigue in narcolepsy with cataplexy.
        J Sleep Res. 2012; 21: 163-169
        • Becker P.M.
        • Schwartz J.R.
        • Feldman N.
        • et al.
        Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
        Psychopharmacology. 2004; 171: 133-139
        • Cuellar N.G.
        • Ratcliffe S.J.
        A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome.
        J Clin Sleep Med. 2008; 4: 50-56
        • Oliveira A.R.
        • Correa F.I.
        • Correa J.C.
        • et al.
        Analysis of fatigue associated to periodic limb movement during sleep in former poliomyelitis patients.
        Rev Neurol. 2012; 54 ([in Spanish]): 24-30